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The amino acid sequence of a large form of inhibin-like peptide in human seminal plasma was determined, 
and compared with structures reported for similar inhibin preparations and a seminal plasma globulin. The 
data confirm and correlate previous reports on this form of inhibin-like peptide. The structural comparisons 
further suggest hat the peptide is closely similar to or possibly identical to a sperm-coating antigen reported 
to be synthesiz& from prostatic epithelium. This may correlate with non-gonadal origins of inhibin-like 
material and will help to elucidate the biological roles of inhibin(s). 
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1. INTRODUCTION 
Inhibin is the name given to the postulated hor- 
mone that has been implicated in the selective sup- 
pression of FSH secretion [l]. The corresponding 
peptide is of presumed gonadal origin and con- 
sidered to decrease the hypophyseal release of FSH 
but not that of LH. It is therefore more selective 
than the gonadal steroid hormones which influence 
both FSH and LH secretion. Further characteriza- 
tions of this peptide have been complicated by 
difficulties with interpretations of bioassays, and 
there is not complete agreement even on the ex- 
istence of the peptide( Furthermore, several pep- 
tides, differing in size and other properties have 
been reported to have inhibin-like activity (cf. 
[2,3]). Finally, similar peptides have been sug- 
gested to occur in gastric secretions [4], in blood 
plasma of gonad~to~z~ individu~s [5], and in 
other organs, raising doubts concerning the 
gonadal origin or functional specificity of inhibin 
activity. 
first purified and its N-terminal structure 
characterized [2]. A completely different structure 
with lower molecular weight was similarly reported 
[3]. A study on sperm antigen analysis [6], which 
was not concerned with inhibin activity, revealed a 
structure related to high-molecular-mass, inhibin- 
like peptide; and the structure of the latter inhibin 
preparation was reported, showing apparent bio- 
activity of a C-terminal fragment [7], possibly 
limited structural similarity to another seminal 
peptide [8], and probable pro-form cleavages [7]. 
All these reports provide new and clearly defined 
standards for further inhibin correlations. Here, ‘a 
separate analysis independent of [7], for the high- 
molecular-mass inhibin-like peptide [2] is reported. 
This allows comparisons between 3 preparations 
([2,7], this work), correlating all data. Com- 
parisons also suggest further conclusions on the 
Orion and biological function(s} of these 
polypeptides, as well as suggesting possible future 
tests. 
Recently, the situation was made clearer by 
several structural studies on inhibin-like peptides 
[2,3,6,7]. Thus, a high-molecular-weight form was 
2. MATERIALS AND METHODS 
Large-form inbibin from human seminal plasma 
was prepared by ethanol precipitation and subse- 
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F&l. Purification of enzymatic peptides from the carboxymethylated large form of the h&i&in-like peptide (peptide 
nomenclature as in fii.2). (A) Left: Sephadex G-50 exclusion chromatography (1.5 x 200 cm; 30% acetic acid) of the 
digest with Glu-specific Staphylococcal protease. Positions of all E-peptides shown in fig.2 are indicated. Bight: 
Purification by reverse-phase HPLC (&ondapak CM; gradient of acetonitrile, %B, in 0.1% trifhroroacetic acid) of 
the fragments corresponding to the EWE6 and E3/E7 mixtures, respectively. (B) Purification of the tryptic digest by 
direct reverse-phase HPLC as in A. 
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quent column chromatographies as previously 
described [2}. The peptide was reduced, carbox- 
~ethylat~ with “C-labelled iodoacetate [Z], and 
subjected to direct sequencer analysis, as well as 
for separate cleavages with CNBr [2], trypsin, 
Staphylococcal Glu-specific protease, and clostri- 
pain. The enzymatic digestions were carried out 
for 4 h at 37’C, with i&bin amounts of 
20-100 nM in 200-500~1 of 0.1-0.2 M am- 
monium bicarbonate and S-5Oyg enzyme (least 
for trypsin, most for ciostripain). Digests were 
purified by reverse-phase high performance liquid 
chromatography (HPLC), using linear gradients of 
acetonitrile in 0.1% ~fluoroacetic acid, as 
described 191. After the treatment with 
Staphyiococcal protease, digests were prefrac- 
tionated by exclusion chromatography on 
Sephadex G-50 in 30% acetic acid [9]. Amino acid 
compositions were determined with a Beckman 
121M analyzer after hydrolysis for 24 h at llO*C 
with 6 M HCl/OS% phenol. Liquid phase se- 
quencer analyses were performed in a Beckman 
8900 instrument in the presence of glycine- 
precycled Polybrene 1101 and using a 0.1 M 
Quadroi peptide program; phenylthiohyd~toins 
were analyzed by reverse-phase HPLC [ii]. 
Manual sequence degradations were carried out by 
the DABITC double coupling method [121, utiliz- 
ing by-products to assist identifications by thin- 
layer c~omatography 1131. 
3. RESULTS 
The primary structure of the i~bin-like peptide 
was determined by liquid-phi sequencer analysis 
of the whole carboxymethyiated peptide, com- 
bined with sequencer-assisted and manual 
degradations of the fragments obtained after 
separate treatments with CNBr, trypsin, 
Staphyl~~~ Glu-specific protease, and clostri- 
pain, respectively. All peptides were purified by 
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Fig.2. Primary structure of the in~bin-Ike peptide anahzed, together with Positions of fragments. Cys residues 
analyzed as Cys(Cm) after reduction and carboxymethylation, but are Iikely to occur as half-cystines in the native 
structure (cf. 1781). Peptides derived from treatments with trypsin are denoted by T, with Glu-specific Staphylococcal 
protease by E, and with CNBr by CN. Numbers give sequential order of all fragments within each set of peptides. 
Regions of peptides identified by Edman degradation (liquid phase sequencer o DAEITC degradations) are given by 
solid lines, regions proven by compositions only by dotted Iines. Low sequence yields of the C-terminaI T6 and E8 
residues are indicated by commas between residues 92-94. Peptides were purified as shown in fig.1, relevant 
compositions are given in table 1. In addition to the fragments shown, the two CNBr fragments were purified as given 
in [2] and 3 peptides after clostripain digestion (Argcleavage) were isolated. 
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reverse-phase HPLC and/or Sephadex G-50 exclu- 
sion chromatography. 
Purifications of the digests with trypsin and the 
Staphylococcal protease are shown in fig.1, and 
analytical results are summarized in fig.2 Com- 
positions of peptides relevant to the deduction of 
the structure are given in table 1. 
4. DISCUSSION 
4.1. Structure analysis 
Most peptides were analyzed with unequivocal 
results, as shown in fig.2, but three minor pro- 
blems were encounters and required further con- 
sideration. One was the approach to analysis of the 
middle region (after position 40) by direct se- 
quencer analysis of the intact peptide or the C- 
terminal CNBr fragment. Thus, such analysis did 
not proceed as far as anticipated because of suc- 
cessive increases in residue carry-over, which ap- 
peared to increase at each of 5 Glu/Gln positions 
between residues 3l-46, ,successively obscuring in- 
terpretation of direct analyses both of the intact 
peptide and of the large CNBr fra~ent. Conse- 
quently, the middle region had to be established by 
isolation and analysis of smaller peptides, obtained 
by enzymatic cleavages, as indicated (E3-E6, 
fig.2). Here, as well as in the C-terminal region, 
partial cleavages, yielding overlapping peptides in 
lower yield were also encountered (W/E6 and 
T3/T4). The T3/T4 doublet of peptides was in- 
completely resolved upon high-~rfo~an~ liquid 
chromato~aphy and was therefore degraded as an 
unresolved mixture, which was sufficient to 
establish the E6/E7 overlap. 
Table 1 
Amino acid compositions of fragments used to deduce the structure of the inhibin-like 
peptide 
Peptide T6 E6 E7 ES CN2 
~CN~~N2~ 
CYS (Cm) 
Asx 
Thr 
Ser 
GlX 
Pro 
GIY 
Ala 
Val 
Met 
Ile 
Leu 
Tyr 
Phe 
Trp 
LYS 
I-I& 
Arg 
Sum 44 25 8 15 75 
5.5 (6) 
6.4 (7) 
5.3 (6) 
3.1 (3) 
6.2 (6) 
1.9 (2) 
2.3 (2) 
- - 
2.0 (2) 
- - 
2.0 (2) 
1.1 (1) 
1.9 (2) 
- - 
+ (1) 
1.9 (2) 
0.8 (1) 
1.0 (1) 
2.7 (3) 
3.4 (3) 
2.1 (2) 
2.2 (2) 
2.4 (2) 
0.9 (1) 
1.1 (1) 
- - 
2.1 (2) 
- - 
1.9 (2) 
1.1 (1) 
1.0 (1) 
0.9 (1) 
- - 
3.0 (3) 
- - 
0.9 (1) 
1.0 (1) 
1.1 (1) 
- - 
- - 
1.2 (1) 
- - 
- - 
- - 
1.9 (2) 
- - 
1.0 (1) 
- - 
0.9 (1) 
- - 
- - 
1.1 (1) 
- - 
- - 
Peptide nomenclature and positions as in fig.2; purifications as in fig.1. Analytical 
values are molar ratios from acid hydrolysis (uncorrected for impurities, destruction, 
or slow release), with integers from the sequence determination within parentheses. 
Data for CNl have been reported before [2], with Met analyzed as Hsl + Hse; Trp in 
CN2 determined after hydrolysis with methane sulfonic acid. Last column gives the 
agreement for fragments corresponding to the whole original peptide 
1.0 (1) 
1.2 (1) 
1.0 (1) 
2.2 (2) 
1.2 (1) 
0.9 (1) 
0.9 (1) 
- - 
1.0 (1) 
- - 
0.7 (1) 
- - 
- - 
- - 
+ (1) 
3.8 (4) 
- - 
7.0 ( 8) 
10.5 (10) 
6.4 ( 7) 
5.9 ( 5) 
10.2 ( 9) 
2.9 ( 3) 
3.4 ( 3) 
0.4 - 
4.4 ( 5) 
- - 
4.5 ( 5) 
2.1 ( 2) 
2.7 ( 3) 
1.0 ( 1) 
1.9 ( 2) 
10.2 (10) 
1.0 ( 1) 
1.1 ( 1) 
8.9 (10) 
12.5 (12) 
7.5 ( 8) 
7.9 ( 7) 
11.4 (10) 
5.0 ( 5) 
5.6 ( 5) 
0.4 - 
5.4 ( 6) 
0.6 ( 1) 
5.5 ( 6) 
2.1 ( 2) 
3.6 ( 4) 
2.0 ( 2) 
1.9 ( 2) 
11.2 (11) 
1.0 ( 1) 
1.9 ( 2) 
94 
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The second problem en~~u~ered was the C- 
terminal structure. The iad 9 residues were not 
completely reliably identified “as phenylthiohydan- 
toin derivatives. Thus, the yield of a tryptophan 
derivative corresponding to residue 92 was ex- 
tremely low and the order of residues 93 and 94 
was hardly distinguishable although PTH-Gly in- 
creased before PTH-IIe on degr?dation of T6. The 
presence of tryptophan in this region was also sup- 
ported by the UV absorption of T6 (fig.1) and by 
direct tryptaphan anaIysis after meth~~ulfo~~ 
acid hydrolysis of the whole peptide. The C- 
terminal order in fig.2 is given within, commas to 
denote the difficulties with these interpretations. 
The final problem was in purity of the starting 
material and in migration of the intact peptide 
upon sodium dodecyl sulphate (SDS)-polyacryl- 
amide gel electrophoresis (PAGE). Thus, con- 
taminants in the starting material increased the 
values for Ala initially deduced from acid hydroly- 
sis of the whole peptide, and the electrophoretic 
migration suggested a longer peptide [2]. Re-puri- 
f&-&ion of CN2 clearly showed the absence of Ala. 
Furthermore, the sum of residues by acid hydroly- 
sis (last column in table 1) and by sequence degra- 
dations (fig.2) agree and prove a size X0-20% 
smaller than at first seemed likely from the electro- 
phoretic migration. 
Consequently, the complete structure is conclud- 
ed to be as given in table 2. This result is also in 
agreement with an independent analysis [?f where 
probfems of a similar nature were encountered, 
proving complete identity between these inhibin 
preparatians a 
4.2. Inhibin us a sperm-coating antigtm 
The large-form inhibin structure is almost iden- 
tical to the structure of a sperm-coating antigen 
reported in [6]. In the preliminary report of the 
sperm-coating antigen [6] only minor deviations 
exist, at two internal positions (39 and 40) and at 
the last two C-terminaI positions. It may be possi- 
ble that the deviations in these two regions reflect 
racial or other differences, However, it also seems 
possible that these deviations are ody apparent, 
especially if the difficulties in the analysis of 
‘sperm-coating antigen’ were similar to those en- 
countered in the analysis of ‘inhibin’ preparations 
(cf. above). In any event, the analyses given in 3 
reports ([6,7], this work), now combine clearly to 
establish that $he sperm-coating antigen, of impor- 
tance in detecting seminal stain in forensic 
medicine [6] and of occurrence as a &globulin in 
human seminal plasma [6], is fully or partly iden- 
tical to the “high-molecular-mass form of inhibin’ 
[2] or ‘@-inhibit’ [7]. 
This fact, derived from structural studies, is also 
relevant to two other previously unexplained 
observations on inhibin-like peptides. Thus, some 
reports suggest hat such peptides, although of 
presumed gonadal origin, may a&o occur in other 
organs f&14] or in gonade~o~~ indi~du~s [S]. 
This is consistent with identity/similarity with 
seminal &globulin, since the latter has an extra- 
gonadd origin, being synthesized by prostatic 
epithelial cells and found in increased concentra- 
tions in serum of patients with prostatic ancer [6]. 
In fact, prostatic origin of inhibin-like peptides has 
also been independently indicated [14]. Further- 
more, observations on recoveries during purifica- 
tion of present inhibin preparations 
the amount of inhibin is larger than might normal- 
ly be expected for a peptide with only hormonal 
function; the amount of the inhibin-like peptide is 
therefore consistent with it being a seminaf plasma 
&globulin [6]. 
Regarding function, the occurrence and amount 
should not be taken to disqualify the present pep- 
tide from being an inhibin-like hormone, since 
some hormones occur in considerable quantities 
even in relation to other factors within a single 
family (like, fur example, insu~-Ike growth fac- 
tor I, IGF-1, which is much more abundant in 
bIood plasma [lS] than the st~ctur~y related in- 
sulin, presumably because most of IGF in plasma 
is associated with a binding protein [16]), 
4.3. Future tests 
The combined results on the structural charac- 
terizations of inhibin moIecules, and the finding of 
peptides identical or nearly identical to previously 
known seminal plasma proteins/sperm antigens, 
offer excellent possibilities for ~ab~s~ng inhibin- 
Iike bioactivities and reiationships, as also pointed 
out in [7]. Already now, the similarity/identity 
with a seminai &globulin of prostatic origin [6] 
suggests that the present peptide may also have a 
non-gonadal origin, consistent with previous im- 
munological studies [4,5]. It therefore appears im- 
portant to repeat these studies with antibodies 
Volume 176, number 1 FEBS LETTERS October 1984 
against defined and synthetic replicates of the 
structure to establish the origin(s) of inbibin. 
The finding of other inbibii-like peptides [3] 
and of active fragments of the present molecule 
[73, as well as the possible similarities with parts of 
an enzyme 131 or with g~ro~t~ti~-bran pro- 
hormones 171 offer fur&r ~~~ti~ for cor- 
relations with origin and function. Finally, the 
availabtiity of an estawished structure will allow 
synthesis of oligonu&&le probes. For all these 
purposes, it is important to have complete agree- 
ment between different preparations ([2,7], this 
work) and regarding assignment of inbibin to a 
known seminal protein of prostatic origin [6]. 
Agreement is now evident from the structuraI 
comparisons. 
ACKNOWLEDGEMENTS 
H. J. acknowledges receipt of the information in 
[6] and 173 during summer conferences 1984 
(Meeting of Federation of American Societies for 
Experimental Biobgy, St. Louis, MO, USA; and 
Fifth Confemmzon Methods in Protein Sequence 
Analysis, ~~b~~e, aids as well as receipt 
of [7] from Dr Seidah before publication. The 
structural studies described in the present report 
and those in [7] were conducted wholly independ- 
ently, even though one investigator (A.S.) parti- 
cipated in both projects. This study was supported 
by grants from the Swedish MedicaJ Research 
Council (project 13X-35323, the Swedish’ Cancer 
Society (project 1806), and the LEO Research 
Foundation. 
REFERENCES 
[l] McCullagh, D.R. (1932) Science 76, 19-F. 
f2] Sheth, A& Arabatti, N., Carlquist, M. and 
Jarnvall, H. (1984) FEBS Lett. 165, 11-15. 
[3] Seidah, N.G., Ramasharma, K., Sairam, M.R. and 
Chrlitien, M. (1984) PBBS Lett. 167, 98-102. 
[4J Sheth, N.A., Vaze, A.Y. and Sheth, A.R. (1982) 
Clin. Endocr. 17, 157-163. 
[S] B&sac, MS., Kahn, S.A., El&son, R., 
Skakkeh+x!k; N.E., Sheth, A.R. and Diczfalusy, E. 
(1984) Int. J. Androl., in press. 
161 Yoshioka, Y., Akiy~a, K., Tsuda, R,, Hara, M., 
Schmid, K., Offner, G.D. and Troxier, RF. (1984) 
Fed. Proc. 43, 1633. 
171 Seidah, N.G., Arbatti, N.J., Rochemont, J., 
Sheth, A.R. and Chretien, M. (1984) FEBS Lett. 
175, 349-35s. 
[8] Esch, F.S., Ling,N.C., Bi%&n, P., Yin& S.Y. and 
Guillemin, R. (1983) Biochem. Biophys. Res. Com- 
mue. 113, 861-867. 
[9] Jeffery, J., Cederlund, E. and Jiirnvall, H. (1984) 
Eur. J. Biochem. 140, 7-16. 
[lo] J&n&l, H. and Philipson, L. (1980) Eur. J. Bio- 
them. 104, 237-247. 
[I l] Zimmerman, C.L., Appelia, E. and Pisano, J. J. 
(1977) Anal. Biochem. 77, 569-573. 
[12] Chang, J.Y., Brauer, D. and W~ttmann-Lie~ld, 
B. (1978) FEBS Lett. 93, 205-214. 
[ 131 Von Bahr-Linds@jm, H., Hempel, J. and Jbrnvall, 
H. (1982) J. Prot. Chem. 1, 257-262. 
[14] Sheth, A.R., Vanage, G.R., Hurkadli, K.S. and 
Sheth, N.A. (1984) Med. Hypothesis, in press. 
1151 Enberg, G., Cariquist, M., JbrnvaU, H. and Hall, 
K. (1984) Eur. J. Biochem., in press. 
[ 161 Pbvoa, G., Enberg, G., Jbrnvall, H. and Hall, K. 
(1984) Eur. J. Biochem., in press. 
26 
